Your browser doesn't support javascript.
loading
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
Peter, Jonny G; Zijenah, Lynn S; Chanda, Duncan; Clowes, Petra; Lesosky, Maia; Gina, Phindile; Mehta, Nirja; Calligaro, Greg; Lombard, Carl J; Kadzirange, Gerard; Bandason, Tsitsi; Chansa, Abidan; Liusha, Namakando; Mangu, Chacha; Mtafya, Bariki; Msila, Henry; Rachow, Andrea; Hoelscher, Michael; Mwaba, Peter; Theron, Grant; Dheda, Keertan.
Afiliação
  • Peter JG; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Clinical Immunology and Allergology, Department of Medicine, University of Cape To
  • Zijenah LS; University of Zimbabwe College of Health Sciences, Department of Immunology, Harare, Zimbabwe.
  • Chanda D; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; University Teaching Hospital, Lusaka, Zambia; Institute for Medical Research & Training, University Teaching Hospital, Lusaka, Zambia.
  • Clowes P; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany.
  • Lesosky M; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Gina P; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Mehta N; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Calligaro G; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Lombard CJ; Biostatistics Unit, South African Medical Research Council, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
  • Kadzirange G; University of Zimbabwe College of Health Sciences, Department of Medicine, Harare, Zimbabwe.
  • Bandason T; Biomedical Research and Training Institute, Harare, Zimbabwe.
  • Chansa A; University Teaching Hospital, Lusaka, Zambia; Institute for Medical Research & Training, University Teaching Hospital, Lusaka, Zambia.
  • Liusha N; University Teaching Hospital, Lusaka, Zambia; Institute for Medical Research & Training, University Teaching Hospital, Lusaka, Zambia.
  • Mangu C; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Mtafya B; Biomedical Research and Training Institute, Harare, Zimbabwe; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Msila H; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Rachow A; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany; German Centre for Infection Research, Munich, Germany.
  • Hoelscher M; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, Munich, Germany; German Centre for Infection Research, Munich, Germany.
  • Mwaba P; University Teaching Hospital, Lusaka, Zambia.
  • Theron G; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for Molecular and Cellular Biology, Divis
  • Dheda K; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Clinical Immunology and Allergology, Department of Medicine, University of Cape To
Lancet ; 387(10024): 1187-97, 2016 Mar 19.
Article em En | MEDLINE | ID: mdl-26970721
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Lipopolissacarídeos / Infecções Oportunistas Relacionadas com a AIDS / Sistemas Automatizados de Assistência Junto ao Leito Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Lipopolissacarídeos / Infecções Oportunistas Relacionadas com a AIDS / Sistemas Automatizados de Assistência Junto ao Leito Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2016 Tipo de documento: Article